IOBT vs REGN: Which Stock is Better?

Side-by-side comparison of Io Biotech Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

IOBT

Io Biotech Inc

$0.01

REGN

Regeneron Pharmaceuticals Inc

$755.51

Key Metrics Comparison

MetricIOBTREGNWinner
Market Cap$3.45M$78.92BREGN
P/E RatioN/A17.99REGN
EPS (TTM)$N/A$41.50REGN
Revenue Growth0.0%0.0%REGN
Gross Margin0.0%44.6%REGN

Analyze IOBT

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is IOBT or REGN a better investment?

Comparing IOBT and REGN: Io Biotech Inc has a market cap of $3.45M while Regeneron Pharmaceuticals Inc has $78.92B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between IOBT and REGN?

IOBT (Io Biotech Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: IOBT or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: IOBT or REGN?

REGN has higher revenue growth at 0.0% vs 0.0% for IOBT.

Which company is more profitable: IOBT or REGN?

Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 44.6% compared to 0.0% for IOBT.

Which is the larger company: IOBT or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $78.92B compared to $3.45M for IOBT.

Should I buy IOBT or REGN in 2026?

Both IOBT and REGN have investment merit. IOBT trades at $0.01 while REGN trades at $755.51. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between IOBT and REGN stock?

Key differences: Market Cap ($3.45M vs $78.92B), P/E Ratio (N/A vs 18.0x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 44.6%).

Popular Stock Comparisons